U.S. Physical Therapy (NYSE:USPH) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS

U.S. Physical Therapy (NYSE:USPH) announced its earnings results on Wednesday. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.76 by $0.04, Zacks reports. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%. The business had revenue of $222.56 million for the quarter, compared to the consensus estimate of $214.48 million. During the same period last year, the business posted $0.66 EPS. The company’s revenue was up 12.9% on a year-over-year basis.

U.S. Physical Therapy Stock Up 8.3%

Shares of NYSE:USPH traded up $7.36 during midday trading on Thursday, hitting $96.54. 139,077 shares of the stock were exchanged, compared to its average volume of 204,536. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.27 and a current ratio of 1.27. U.S. Physical Therapy has a 52-week low of $58.19 and a 52-week high of $100.98. The business’s fifty day simple moving average is $83.40 and its two-hundred day simple moving average is $76.92. The company has a market capitalization of $1.44 billion, a PE ratio of 568.53, a P/E/G ratio of 2.15 and a beta of 1.16.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 11th. Investors of record on Monday, November 16th will be given a dividend of $0.46 per share. The ex-dividend date of this dividend is Monday, November 16th. This represents a $1.84 dividend on an annualized basis and a yield of 1.9%. U.S. Physical Therapy’s payout ratio is presently 1,082.35%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th. Barrington Research lifted their price objective on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. Finally, JPMorgan Chase & Co. boosted their target price on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, September 11th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, U.S. Physical Therapy has an average rating of “Moderate Buy” and a consensus price target of $98.25.

More U.S. Physical Therapy News

Here are the key news stories impacting U.S. Physical Therapy this week:

• Positive Sentiment: Q3 results beat estimates: USPH reported earnings of $0.80 per share, above the $0.76 consensus, and revenue of $222.56 million versus forecasts of $214.48 million. Revenue increased 12.9% year over year. The company highlighted record visits and revenue per visit, reinforcing evidence of operating growth. USPH Q3 2026 results
• Positive Sentiment: Quarterly dividend declared: The company announced a $0.46-per-share dividend, payable December 11 to shareholders of record November 16. The annualized payout is $1.84 per share, equivalent to a reported 2.1% yield.
• Neutral Sentiment: A transcript of the Q3 earnings call was published, but the supplied article details do not identify additional guidance or developments beyond the reported results. Q3 2026 earnings call transcript

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.